orth Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer(NORTH/HGCSG1003 study)
Phase 2
- Conditions
- Colon Cancer
- Registration Number
- JPRN-UMIN000004590
- Lead Sponsor
- PO Hokkaido Gastrointestinal Cancer Study Group (HGCSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 270
Inclusion Criteria
Not provided
Exclusion Criteria
1)Multiple cancer patient 2)Patients who had other cancer within 5 years. 3)Pregnant or lactating women. 4)Patients who had colorectal cancer excluded mucosal cancer. 5)Peripheral sensory neuropathy or Paresthesia(CTCAE v4.0 >= Grade 1). 6)Uncontrolled congestive heart failure or angina pectoris, or hypertension or arrhythmia. 7)History of significant neurologic or psychiatric disorders. 8)Active infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method three-year disease-free survival rate
- Secondary Outcome Measures
Name Time Method 1)overall survival 2)relative dose intensity 3)adverse event